News
-
-
COMMUNIQUÉ DE PRESSE
DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany
DocMorris AG reports significant earnings improvement in 2023 as e-prescription becomes standard in Germany. Break-even program successful. Outlook for 2024 includes over 10% external revenue growth -
-
COMMUNIQUÉ DE PRESSE
DocMorris: Solid basis for sustainable, profitable growth
-
-
-
-
COMMUNIQUÉ DE PRESSE
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)